Weisel, Katja Dimopoulos, Meletios A. van de Donk, Niels W. C. J. Ramasamy, Karthik Gamberi, Barbara Streetly, Matthew and Offidani, Massimo Bridoux, Frank de la Rubia, Javier and Kueenburg, Elisabeth Lersch, Frederik Rosettani, Barbara and Bacon, Pamela Sonneveld, Pieter, Safety Results of a Phase 2 Multicenter, Open-Label Study of
Pomalidomide (CC-4047) Plus Low-Dose Dexamethasone in Patients with
Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment, Blood advances, (128), 2016, AMER SOC HEMATOLOGY,